Avalo Therapeutics, INC. (AVTX) SEC Filings — 2025

Filings

• Avalo Therapeutics Files 8-K — 8-K · Dec 2, 2025
• Avalo's Losses Mount Amid Soaring R&D Costs, Cash Dwindles — 10-Q · Nov 6, 2025
• Avalo Therapeutics Files 8-K — 8-K · Oct 29, 2025
• Avalo Therapeutics Files 8-K — 8-K · Oct 10, 2025
• Avalo Therapeutics Reports Director/Officer Changes & More — 8-K · Oct 1, 2025
• Avalo Therapeutics Files 8-K on Officer/Director Changes — 8-K · Sep 22, 2025
• Avalo Therapeutics Reports Zero Revenue, Deepening Losses in Q2 — 10-Q · Aug 7, 2025
• Avalo Therapeutics Files 8-K — 8-K · Jun 20, 2025
• Avalo Therapeutics Announces Board Changes and Executive Compensation Updates — 8-K · Jun 18, 2025
• Avalo Therapeutics Files 8-K on Security Holder Vote — 8-K · Jun 17, 2025
• Avalo Therapeutics Announces Material Agreements — 8-K · Jun 5, 2025
• Avalo Therapeutics Files 8-K — 8-K · Jun 4, 2025
• Avalo Therapeutics Files Q1 2025 10-Q — 10-Q · May 12, 2025
• Avalo Therapeutics Files 8-K — 8-K · May 8, 2025
• Avalo Therapeutics Files 2025 Proxy Statement — DEF 14A · May 1, 2025
• Avalo Therapeutics Files 8-K on Director/Officer Changes — 8-K · Mar 26, 2025
• Avalo Therapeutics Files 2024 10-K — 10-K · Mar 20, 2025
• Avalo Therapeutics Files 8-K — 8-K · Jan 13, 2025
• Avalo Therapeutics Files 8-K on Officer/Director Changes — 8-K · Jan 2, 2025